Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
294 studies found for:    Open Studies | "Ear Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
Interventions: Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin
22 Recruiting Cochlear Implant Low Power Strategy
Condition: Hearing Loss
Intervention: Device: MP3000 sound coding strategy or ACE strategy with lower stimulation
23 Not yet recruiting Shared Decision Making in Parents of Children With Acute Otitis Media
Condition: Acute Otitis Media
Interventions: Other: Acute Otitis Media Choice Decision Aid;   Other: Usual Care
24 Recruiting Vibrotactile Feedback During Vestibular Therapy
Condition: Vestibular Disease
Intervention: Other: Vibrotactile Feedback
25 Not yet recruiting Intracochlear Potentials: Volta Study
Condition: Hearing Loss
Interventions: Device: SA16 research software;   Device: CS19 (1.6.2)
26 Recruiting Effectiveness of Manual Therapy in Patients With Tinnitus and Temporomandibular Joint Disorder.
Condition: Tinnitus
Interventions: Other: Conventional Physiotherapy;   Other: Specific Manual Therapy
27 Not yet recruiting Examining the Impact of Physician Influence on Hearing Aid User Satisfaction and Retention
Condition: Hearing Loss
Interventions: Other: Physician counselling and assessment;   Other: Audiologist counselling and assessment
28 Recruiting Wolfram Syndrome International Registry and Clinical Study
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
Intervention:
29 Recruiting The Accuracy of Automated Audiometry Application on Smart Phone to Screen Hearing Loss
Condition: Hearing Loss
Intervention:
30 Not yet recruiting Hearing Aid Education and Adaptation System
Condition: Hearing Loss
Intervention: Other: TELLYHealth
31 Recruiting Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
Conditions: Hearing Loss;   Hearing Impairment
Interventions: Drug: AUT00063;   Drug: Placebo
32 Recruiting AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Conditions: Neurofibromatosis 2;   Meningioma
Intervention: Drug: AZD2014
33 Not yet recruiting A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
Intervention: Drug: dantrolene sodium
34 Recruiting Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study
Condition: Tinnitus
Interventions: Device: Neuromonics Tinnitus Treatment Program;   Device: Placebo Device
35 Not yet recruiting Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Condition: Autoimmune Neurosensory Hearing Loss (ANSHL)
Intervention: Drug: Rilonacept
36 Recruiting North Carolina Newborn Exome Sequencing for Universal Screening
Conditions: Metabolism, Inborn Errors;   Hearing Loss;   Hereditary Disease
Interventions: Genetic: Well infant, whole exome sequencing;   Genetic: Diagnosed, whole exome sequencing
37 Recruiting A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea
Conditions: Otitis Media;   Otorrhea
Interventions: Drug: piperacillin 4% + tazobactam 0.5% + dexamethasone 0.1%;   Drug: piperacillin 8% + tazobactam 1.0% + dexamethasone 0.1%;   Drug: piperacillin 2% + tazobactam 0.25%;   Drug: piperacillin 4% + tazobactam 0.5%;   Drug: piperacillin 8% + tazobactam 1.0%
38 Not yet recruiting Resiliency Training for Patients With NF2 Via Videoconferencing With Skype
Condition: Neurofibromatosis 2
Interventions: Behavioral: Stress Management Group 1;   Behavioral: Stress Management Group 2
39 Not yet recruiting Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo
Condition: Benign Paroxysmal Positional Vertigo
Intervention: Behavioral: DIZZTINCT
40 Recruiting Phase 3 Study of OTO-201 in Acute Otitis Externa
Conditions: Acute Otitis Externa;   Swimmer's Ear
Interventions: Drug: 12 mg ciprofloxacin;   Drug: Sham Control

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years